Antiviral activities of hemp cannabinoids
Clinical Science · 2023
DOI: 10.1042/cs20220193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2023. Verfasst von Richard B van Breemen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW …. Hauptthemen laut MEDLINE: Cannabis, COVID-19, Cannabinoids, Cannabidiol. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW Campus Drive, Corvallis, OR 97331, U.S.A.
ORCID-Profile: Richard B van Breemen
Zitieren
APA
van Breemen, R. B., & Simchuk, D. (2023). Antiviral activities of hemp cannabinoids. Clinical Science. https://doi.org/10.1042/cs20220193
Vancouver
van Breemen RB, Simchuk D. Antiviral activities of hemp cannabinoids. Clinical Science. 2023. doi:10.1042/cs20220193
BibTeX
@article{vanBreemen2023,
author = {van Breemen, Richard B and Simchuk, Daniel},
title = {Antiviral activities of hemp cannabinoids},
journal = {Clinical Science},
year = {2023},
doi = {10.1042/cs20220193}
}
EUVIMED